Skip to main content
. 2024 Nov 20;31(11):7414–7425. doi: 10.3390/curroncol31110547

Table 1.

Background characteristics of participants (n = 144).

Variable M (SD), Range
Age in Years 58 (12.2), 27–83
N (%)
Sex
      Male 54 (36%)
      Female 90 (63%)
Education level according to ISCED 2011 [27]
      Low 13 (9%)
      Medium 47 (33%)
      High 84 (58%)
Type of cancer (multiple answers possible)
      Breast 62 (43%)
      Urological 30 (21%)
      Gastrointestinal 18 (13%)
      Skin 14 (10%)
      Blood or lymph 12 (8%)
      Gynecological 8 (6%)
      Lung 8 (6%)
      Head or neck 6 (4%)
      Other 4 (3%)
Treatment status
      In active treatment 82 (57%)
      Post-treatment (≥6 months) 41 (28%)
      Other a 21 (15%)
Current complementary medicine (CM) user
      Yes, CM use discussed with HCP b 34 (24%)
      Yes, CM use not discussed with HCP 19 (13%)
      No, but interested in CM or former user 61 (42%)
      No, not interested in CM 30 (21%)
Recruited through
      Patient panel 92 (64%)
      Hospital 27 (19%)
      Breast cancer society 25 (17%)

The percentages may add to less or more than 100% due to rounding. a E.g., awaiting treatment, regular check-ups, wait-and-see, and palliative treatment. b Healthcare provider.